Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.

Foscarnet has been shown to be active in vitro against the human immunodeficiency virus and all human herpesviruses including cytomegalovirus (CMV). A pharmacokinetic study was carried out as part of a clinical trial designed to evaluate the safety and efficacy of intermittently administered intrave...

Full description

Saved in:
Bibliographic Details
Main Authors: Aweeka, F, Gambertoglio, J, Mills, J, Jacobson, M A
Format: Artigo
Language:Inglês
Published: 1989
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC172525/
https://ncbi.nlm.nih.gov/pubmed/2546491
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items